Change in sexual risk behaviour after 6 months of pre-exposure prophylaxis use: results from the Amsterdam pre-exposure prophylaxis demonstration project

被引:0
|
作者
Hoornenborg, Elske [1 ,2 ]
Coyer, Liza [1 ]
van Laarhoven, Anna [1 ]
Achterbergh, Roel [1 ,2 ]
de Vries, Henry [1 ,2 ,3 ]
Prins, Maria [1 ,4 ]
van der Loeff, Maarten Schim [1 ,4 ]
机构
[1] Publ Hlth Serv Amsterdam, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands
[2] Publ Hlth Serv Amsterdam, Clin Sexually Transmitted Infect, Dept Infect Dis, Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Amsterdam, Netherlands
[4] Univ Amsterdam, AIII, Acad Med Ctr, Dept Infect Dis, Amsterdam, Netherlands
关键词
HIV; MSM; pre-exposure prophylaxis; risk compensation; sexual behaviour; HIV PREVENTION; MEN; INFECTIONS; SAFETY; COHORT;
D O I
10.1097/QAD.0000000000001874
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: HIV pre-exposure prophylaxis (PrEP) use may lead to higher STI incidence via behavioural risk compensation. We examined changes in sexual behaviour between baseline and 6 months after PrEP initiation among MSM and transgender women (TGW). Design: Prospective, open-label demonstration study at a large sexually transmitted infection (STI) clinic in Amsterdam, the Netherlands. Methods: Participants answered questions about sexual behaviour in the preceding 3 months, including number of anal sex partners and frequency of anal sex with and without condom by partner type and were tested for STI. Sexual behaviour at baseline was compared with 6 months after PrEP initiation using Wilcoxon signed rank tests. Logistic regression was used to identify factors associated with an increase in receptive condomless anal sex acts (rCASa) with casual partners. Results: Data were available for 328 (99%) MSM and 2 (1%) TGW. The number of receptive and insertive condomless anal sex acts (CASa) increased (baseline: median 11, interquartile range 4-23; 6 months: median 14, interquartile range 6-26, P<0.001), whereas the number of anal sex partners (P = 0.2) and anal sex acts (P = 0.8) remained unchanged. Prevalence of STI was stable. Older age, prior engagement in chemsex, recent use of postexposure prophylaxis and choosing a daily PrEP regimen at baseline were associated with an increase in rCASa with casual partners. Conclusion: Over the first 6 months after initiation of PrEP, an increase in insertive and receptive CASa with casual partners was observed. Long-term follow-up data are needed and STI incidence needs to be closely monitored. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:1527 / 1532
页数:6
相关论文
共 50 条
  • [1] Concordance between daily diary reported pre-exposure prophylaxis intake and intraerythrocytic tenofovir diphosphate in the Amsterdam Pre-exposure Prophylaxis demonstration project
    Wijstma, Eline S.
    Jongen, Vita W.
    Boyd, Anders
    van den Elshout, Mark A. M.
    de Vries, Henry J. C.
    Davidovich, Udi
    Anderson, Peter L.
    Prins, Maria
    Hoornenborg, Elske
    van der Loeff, Maarten F. Schim
    AIDS, 2024, 38 (08) : 1248 - 1256
  • [2] Results from a Pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender Women in the United States
    Blumenthal, Jill
    Jain, Sonia
    He, Feng
    Amico, K. Rivet
    Kofron, Ryan
    Ellorin, Eric
    Stockman, Jamila K.
    Psaros, Christina
    Ntim, Gifty M.
    Chow, Karen
    Anderson, Peter L.
    Haubrich, Richard
    Corado, Katya
    Moore, David J.
    Morris, Sheldon
    Landovitz, Raphael J.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : 1149 - 1156
  • [3] Pre-exposure prophylaxis adherence and discontinuation at an urban pre-exposure prophylaxis program in Atlanta, Georgia
    Yacout, Hiba
    Smith, Bradley L.
    Foster, Shelbie
    Lora, Meredith
    Niles-Carnes, Larisa V.
    Zheng, Ziduo
    Kundu, Suprateek
    Cantos, Valeria D.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2023, 6 (06): : 576 - 580
  • [4] Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIV
    Milam, Joel
    Jain, Sonia
    Dube, Michael P.
    Daar, Eric S.
    Sun, Xiaoying
    Corado, Katya
    Ellorin, Eric
    Blumenthal, Jill
    Haubrich, Richard
    Moore, David J.
    Morris, Sheldon R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 80 (01) : E9 - E13
  • [5] HIV Pre-Exposure Prophylaxis
    Liegeon, Geoffroy
    Delaugerre, Constance
    Molina, Jean-Michel
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2024, 38 (03) : 453 - 474
  • [6] Sexual behaviour among users of antiretroviral pre-exposure prophylaxis
    Underhill, Kristen
    Mayer, Kenneth H.
    LANCET INFECTIOUS DISEASES, 2013, 13 (12): : 996 - 997
  • [7] Belgian 2024 guidance on the use of pre-exposure prophylaxis
    Van Praet, Jens T.
    Henrard, Sophie
    Kenyon, Chris
    Libois, Agnes
    Meuwissen, Annelies
    Sauvage, Anne-Sophie
    Vincent, Anne
    Vanhamel, Jef
    Scheerder, Gert
    ACTA CLINICA BELGICA, 2024, 79 (02) : 121 - 129
  • [8] Post-exposure prophylaxis in the era of pre-exposure prophylaxis
    Atim, M.
    Girometti, N.
    Hyndman, I
    McOwan, A.
    Whitlock, G.
    HIV MEDICINE, 2020, 21 (10) : 668 - 670
  • [9] Online Prescriptions to HIV Pre-Exposure Prophylaxis and Pre-Exposure Prophylaxis Uptake
    Wille, Lexie
    Parent, Mike C.
    AIDS PATIENT CARE AND STDS, 2020, 34 (12) : 499 - 501
  • [10] Pre-exposure Prophylaxis in LGBT Communities
    Radix, Asa
    Vail, Rona
    PRIMARY CARE, 2021, 48 (02): : 299 - 310